Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel
Oncology · 2025
DOI: 10.1159/000548121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2025. Verfasst von Vincenzo Macaione und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy, vmacaione@unime.it. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Introduction
Among malignant brain tumors, glioblastoma (GB) is one of the most common. An early diagnosis would benefit the prognosis: in this regard, the search for sensitive and specific biomarkers is particularly active. In fact, liquid biopsy has been proposed by many researchers as a valid and repeatable method of studying GB. Among the biomarkers researched in blood patients, microRNAs (miRNAs) are among the most encouraging. The aim of our research was to select blood miRNAs overexpressed in GB patients to establish a reliable biomarker panel for pathology.
Methods
We studied blood expression of 14 miRNAs in 30 subjects with GB, before and after surgery, and 30 healthy controls.
Results
Statistical analysis allowed us to select a panel of 3 miRNAs (miR-340-5p, miR-369-3p, miR-486-5p) that are overexpressed in GB patients.
Conclusion
Our results showed that simultaneous measurement of circulating miR-340-5p, miR-369-3p, and miR-486-5p represents a promising biomarker for the diagnosis and follow-up of GB patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy, vmacaione@unime.it.
- Department of Head and Neck Surgery, Garibaldi Hospital of Catania, Catania, Italy.
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
- Departement of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
Zitieren
APA
Macaione, V., Graziano, F., Polito, F., Scalia, G., Licitri, L., Khouyyi, M., Torre, M. M., Drago, S. F. A., Migliorato, A., Nicoletti, G. F., Cardali, S. M., La Torre, D., & Aguennouz, M. A. H. (2025). Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel. Oncology. https://doi.org/10.1159/000548121
Vancouver
Macaione V, Graziano F, Polito F, Scalia G, Licitri L, Khouyyi M, et al. Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel. Oncology. 2025. doi:10.1159/000548121
BibTeX
@article{Macaione2025,
author = {Macaione, Vincenzo and Graziano, Francesca and Polito, Francesca and Scalia, Gianluca and Licitri, Laura and Khouyyi, Marieme and Torre, Margherita Maria and Drago, Selene Francesca Anna and Migliorato, Alba and Nicoletti, Giovanni Federico and Cardali, Salvatore Massimiliano and La Torre, Domenico and Aguennouz, M Apos Hammed},
title = {Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel},
journal = {Oncology},
year = {2025},
doi = {10.1159/000548121}
}
EUVIMED